Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase Type 1

Details for Australian Patent Application No. 2005207925 (hide)

International Classifications

Event Publications

17 August 2006 PCT application entered the National Phase

PCT publication WO2005/073200 Priority application(s): WO2005/073200

4 September 2008 Application Accepted

Published as AU-B-2005207925

8 January 2009 Standard Patent Sealed

21 January 2010 Amendment Made

The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

11 October 2012 Alteration of Name

The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.